Realbotix generated $132,000 in revenue from its humanoid robotics business in the third quarter of fiscal 2026, up from no robotics revenue in the same quarter last year. The figure provides an early indication that the company’s shift from demonstrations toward commercial deployments is beginning to generate sales, although the robotics operation remains small compared with its cost base.
Realbotix LLC, the subsidiary responsible for the company’s humanoid robots, generated $132,000 in the three months ended June 30 and $184,000 over the first nine months of the fiscal year. This means that more than 70% of its year-to-date robotics revenue was recorded in the latest quarter. The company attributed the increase to completed robot deliveries and support services related to events.
The robotics activities accounted for about 37% of Realbotix Corp.’s consolidated quarterly revenue of $354,000. That total was nevertheless down 40% from $595,000 in the same quarter a year earlier. Over the first nine months, group revenue declined from $2.14 million to $932,000.
The comparison reflects the changing composition of Realbotix. The holding company consists of Realbotix LLC and Intima LLC, a separate consumer business. Revenue from Intima fell to $222,000 in the quarter from $595,000 a year earlier. Realbotix says the previous year’s figure benefited from the fulfillment of an existing order backlog. The company has also discontinued crypto-staking activities as it redirects resources toward robotics and AI.
Costs remain high
The move into robotics is still expensive. Realbotix says its robotics subsidiary has historically generated less than 5% of group revenue while accounting for around 65% of operating costs. The balance is beginning to shift as robot sales appear, but the financial results show that commercialization is still at an early stage.
Operating expenses increased to $1.82 million in the quarter, compared with $1.32 million a year earlier. For the first nine months, operating expenses reached $5.33 million. Realbotix attributes the increase mainly to hiring for its humanoid robotics and AI operations and investments in manufacturing capacity. Its robotics, AI and engineering workforce has grown from eight employees a year ago to more than 20 full-time equivalents.
Gross margin fell from 37.1% to 24.4%. According to the company, this was partly due to manufacturing scale-up costs, the economics of initial robot deployments and an accounting adjustment involving overhead costs. The group reported a comprehensive loss of $1.70 million for the quarter, compared with comprehensive income of $12,000 in the corresponding period last year.
The latest quarter was, however, an improvement on Q2 in terms of sales. Consolidated revenue increased from $225,000 in the previous quarter to $354,000, while gross margin recovered from minus 1.7% to 24.4%. The negative Q2 margin included a one-time accounting adjustment.
From demonstrations to deployments
Realbotix has spent much of the past two years demonstrating its human-like robots and is now trying to convert that exposure into commercial deployments. The company reports projects involving a telecommunications company, senior residences, education and television. It recognizes revenue when robots are delivered, meaning announced projects do not necessarily appear immediately in quarterly sales.
The next step is intended to be a robot line tentatively called Echo Generation One. Realbotix has moved into new facilities in Nevada and says the new range will be designed to be easier to manufacture, with online ordering and scaled production targeted for 2027.
Realbotix LLC is also scheduled to become part of Nasdaq-listed Onconetix through a previously announced reverse takeover. Realbotix expects the transaction to close in the fourth quarter of 2026 and to retain majority ownership of the robotics business following the all-share transaction.
